Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;19(1):217-219.
doi: 10.1007/s11739-023-03482-7. Epub 2024 Jan 11.

Antiphospholipid syndrome: are old school VKAs still the best choice?

Marta Chiara Sircana  1 , Giulia Crisci  2 , Federica Giardino  2 , Chiara Pisetta  3 , Nicola Bonadia  4 ; Scuola di Metodologia della Ricerca SIMI
Affiliations

Antiphospholipid syndrome: are old school VKAs still the best choice?

Marta Chiara Sircana et al. Intern Emerg Med. 2024 Jan.
No abstract available

Keywords: Anti-phospholipid syndrome; Anticoagulant therapy; Comparative efficacy studies; Direct-acting oral anticoagulants; Meta-analysis; Therapeutic interventions; Thrombosis.

PubMed Disclaimer

References

    1. Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304. https://doi.org/10.1136/annrheumdis-2019-215213 - DOI - PubMed
    1. Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, De Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RHWM, De Groot PGD, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris J-C, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74:1011–1018. https://doi.org/10.1136/annrheumdis-2013-204838 - DOI - PubMed
    1. Khairani CD, Bejjani A, Piazza G, Jimenez D, Monreal M, Chatterjee S, Pengo V, Woller SC, Cortes-Hernandez J, Connors JM, Kanthi Y, Krumholz HM, Middeldorp S, Falanga A, Cushman M, Goldhaber SZ, Garcia DA, Bikdeli B (2023) Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol 81:16–30. https://doi.org/10.1016/j.jacc.2022.10.008 - DOI - PubMed
    1. Giarretta I, Ageno W, Dentali F (2022) Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome. Haematologica 107:2737–2741. https://doi.org/10.3324/haematol.2022.281586 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources